Allmed Medical(SZ:002950) Xin Lang Cai Jing·2026-01-05 02:28Group 1 - The core viewpoint of the news is that Aomei Medical has shown a mixed performance in its stock price and financial results, with a slight increase in stock price recently but a decline over the past few trading days [1][2]. - As of January 5, Aomei Medical's stock price increased by 2.01% to 11.14 CNY per share, with a market capitalization of 7.055 billion CNY [1]. - The company reported a revenue of 2.597 billion CNY for the first nine months of 2025, representing a year-on-year growth of 5.98%, and a net profit of 349 million CNY, which is a 31.54% increase compared to the previous year [2]. Group 2 - Aomei Medical's main business involves the research, production, and sales of disposable medical consumables, with the revenue composition being 79.19% from surgical and wound care, 6.62% from other categories, 5.05% from infection protection, 4.68% from advanced dressings, and 4.46% from hygiene care [1]. - The company has distributed a total of 1.099 billion CNY in dividends since its A-share listing, with 91.913 million CNY distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders increased to 37,800, with an average of 11,965 circulating shares per person, a decrease of 0.71% [2][3].